Edward M. Kaye, MD

February 26th, 2024|Categories: Featured Members|

Edward M. Kaye, M.D. Chief Executive Officer and Director of Stoke Therapeutics How did you become interested in the field? My interest in genetic medicine began as a biochemical geneticist and pediatric neurologist. Back in the 1990s, when I was treating patients, I saw first-hand ...

Interview with Shipra Malik, PhD

February 1st, 2023|Categories: Featured Members|

Shipra Malik, PhDRaman Bahal LabDepartment of Pharmaceutical SciencesUniversity of Connecticut How did you become interested in the field of oligonucleotides? Being from pharmaceutics background, my master’s research was focused on designing nano-formulations to improve the local delivery of small molecules. As I was looking for ...

Interview with M.Sc. Philipp Niklas Ostermann, PhD Student

June 1st, 2022|Categories: Featured Members|

M.Sc. Philipp Niklas Ostermann PhD Student Heiner Schaal Lab Institute of Virology University Hospital DĂ¼sseldorf How did you become interested in the field of oligonucleotides? I first encountered the use of antisense oligonucleotides as potential therapeutics during my master’s thesis, which was about inhibition of ...

Go to Top